PARP-1 expression as a prognostic factor in Desmoid-type fibromatosis-Reference-Cited by-同舟云学术

PARP-1 expression as a prognostic factor in Desmoid-type fibromatosis

Published:2020-02 Issue: Volume:44 Page:151442
ISSN:1092-9134
Container-title:Annals of Diagnostic Pathology
language:en
Short-container-title:Annals of Diagnostic Pathology

Author:

Bräutigam Konstantin^ORCID,Lindner Judith,Budczies Jan^ORCID,Pahl Stefan,Kunitz Annegret,Melcher Ingo,Wust Peter,Nebrig Maxim,Baur Alexander,Denkert Carsten^ORCID,Pfitzner Berit

Publisher

Elsevier BV

Subject

General Medicine,Pathology and Forensic Medicine

Reference25 articles.

1. Time trends in the incidence and treatment of extra-abdominal and abdominal aggressive fibromatosis: a population-based study;van Broekhoven;Ann Surg Oncol,2015

2. Near universal detection of alterations in CTNNB1 and Wnt pathway regulators in desmoid-type fibromatosis by whole-exome sequencing and genomic analysis;Crago;Genes Chromosomes Cancer,2015

3. Specific mutations in the beta-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors;Lazar;Am J Pathol,2008

4. An update on the management of sporadic desmoid-type fibromatosis: a European Consensus Initiative between Sarcoma PAtients EuroNet (SPAEN) and European Organization for Research and Treatment of Cancer (EORTC)/Soft Tissue and Bone Sarcoma Group (STBSG);Kasper;Ann Oncol,2017

5. Advanced aggressive fibromatosis: effective palliation with chemotherapy;Constantinidou;Acta Oncol,2011

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel insights into biomarkers of progression in Desmoid tumor;Frontiers in Oncology;2023-08-03

2. Molecular-genetic landscape of abdominal and retroperitoneal desmoid fibromatosis: a retrospective study;Journal of Modern Oncology;2023-05-17

3. Management of Desmoid Tumors;Surgical Oncology Clinics of North America;2022-07

4. Molecular Pathogenesis of Sporadic Desmoid Tumours and Its Implications for Novel Therapies: A Systematised Narrative Review;Targeted Oncology;2022-04-21

5. Development, Validation, and Visualization of A Web-Based Nomogram for Predicting the Recurrence-Free Survival Rate of Patients With Desmoid Tumors;Frontiers in Oncology;2021-02-25